Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Clinical trial NCT00004132 · COMPLETED

Trial details

NCT number: NCT00004132
Sponsor: Jonsson Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Oral Complications Radiation Toxicity

Start date: 2000-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.